PROGESTERONE INJ 50MG/ML USP 50 MG
PROGESTERONE : 50 MG · DIN 01977652 · CYTEX PHARMACEUTICALS INC
Health Canada status: DORMANT
What is PROGESTERONE INJ 50MG/ML USP?
PROGESTERONE INJ 50MG/ML USP 50 MG contains PROGESTERONE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 01977652, held by CYTEX PHARMACEUTICALS INC, supplied as LIQUID for INTRAMUSCULAR administration. Health Canada currently lists it as dormant, status dated 16-Jun-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is PROGESTERONE INJ 50MG/ML USP called?
The same molecule, PROGESTERONE, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Utrogestan | Latin | Australia, Czechia, Morocco, Saudi Arabia, South Africa |
| AMELGEN | Latin | Czechia |
| Oripro | Latin | Australia |
| PROGESTERON BESINS | Latin | Czechia |
| PROLUTEX | Latin | Bahrain, Czechia, Saudi Arabia |
| Crinone | Latin | Bahrain, Saudi Arabia |
| CYCLOGEST | Latin | Bahrain |
| Endometrin | Latin | Australia, Bahrain |
| GYNPRODYL | Latin | Czechia |
| PROGESTA | Latin | Bahrain |
| PROGESTERONE-APX | Latin | Australia |
| Prometrium | Latin | Australia |
| AGOLUTIN | Latin | Czechia |
| BIOGEST | Latin | Bahrain |
| Endometrin® | Latin | United Arab Emirates |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 01977652 |
|---|---|
| Brand name | PROGESTERONE INJ 50MG/ML USP |
| Generic / active ingredient | PROGESTERONE : 50 MG |
| Manufacturer | CYTEX PHARMACEUTICALS INC |
| Strength | 50 MG |
| Dosage form | LIQUID |
| Route of administration | INTRAMUSCULAR |
| Schedule | Prescription |
| ATC code | G03DA04 PROGESTERONE |
| AHFS class | 68:08.00 |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 16-Jun-2017 |
| Original market date | 1992-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 01977652 |
|---|---|
| DIN (unpadded, as printed on some documents) | 1977652 |
| Brand name | PROGESTERONE INJ 50MG/ML USP |
| Active ingredient / INN | PROGESTERONE : 50 MG |
| ATC code | G03DA04 |
| ATC anatomical main group | G — Genito-urinary system and sex hormones |
| ATC therapeutic subgroup | G03 |
| AHFS class | 68:08.00 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | CYTEX PHARMACEUTICALS INC |
Which pack is which?
| Strength on the label | 50 MG |
|---|---|
| Dosage form | LIQUID |
| Route | INTRAMUSCULAR |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Is PROGESTERONE in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by SANIS HEALTH INC (Tier 3 Drug Shortages About & Resources), last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code G03DA04 PROGESTERONE. 9 of 17 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACT PROGESTERONE INJECTION | 50 MG | SOLUTION | TEVA CANADA LIMITED | MARKETED | DIN 02446820 |
| AURO-PROGESTERONE | 100 MG | CAPSULE | AURO PHARMA INC | MARKETED | DIN 02493578 |
| CRINONE | 8 % | GEL | EMD SERONO, A DIVISION OF EMD INC., CANADA | MARKETED | DIN 02241013 |
| PMS-PROGESTERONE | 100 MG | CAPSULE | PHARMASCIENCE INC | MARKETED | DIN 02476576 |
| PROGESTERONE | 100 MG | CAPSULE | SANIS HEALTH INC | MARKETED | DIN 02516187 |
| PROGESTERONE INJECTION, USP | 50 MG | SOLUTION | HIKMA CANADA LIMITED | MARKETED | DIN 02531828 |
| PROMETRIUM | 100 MG | CAPSULE | ORGANON CANADA INC. | MARKETED | DIN 02166704 |
| REDDY-PROGESTERONE | 100 MG | CAPSULE | DR. REDDY'S LABORATORIES INC | MARKETED | DIN 02463113 |
| TEVA-PROGESTERONE | 100 MG | CAPSULE | TEVA CANADA LIMITED | MARKETED | DIN 02439913 |
| ENDOMETRIN | 100 MG | VAGINAL TABLET, EFFERVESCENT | FERRING INC | DORMANT | DIN 02334992 |
Who else supplies PROGESTERONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PROGESTERONE appears in 127 registered pack listings across 11 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does PROGESTERONE cost around the world?
PROGESTERONE is listed on 13 national price registers Nexara tracks, across 121 pack listings published on 11 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 4 | 23 | 03 Sep 2026 |
| Australia | ex-manufacturer | 8 | 15 | 08 Sep 2026 |
| Czechia | max producer price (ex-factory) | 6 | 13 | 03 Sep 2026 |
| Greece | producer price (ex-factory) | 12 | 12 | 03 Sep 2026 |
| Bahrain | retail (max) | 8 | 10 | 01 Sep 2026 |
| Luxembourg | reimbursement | 9 | 9 | 05 Sep 2026 |
| Saudi Arabia | public | 7 | 8 | 01 Sep 2026 |
| Italy | prezzo al pubblico (classe A) | 7 | 7 | 02 Sep 2026 |
| Hungary | producer price (ex-factory) | 6 | 6 | 03 Sep 2026 |
| Morocco | PPV (public price) | 3 | 6 | 05 Sep 2026 |
| South Africa | single exit price | 6 | 6 | 01 Sep 2026 |
| United Arab Emirates | public | 4 | 4 | 31 Aug 2026 |
| Austria | KVP (Kassenverkaufspreis) | 2 | 2 | 03 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.